115 related articles for article (PubMed ID: 32125225)
1. Actin‑like protein 8 executes a promoting function in the malignant progression of endometrial cancer: identification of a promising biomarker.
Li L; Cheng GH; Chen C; Ma DM; Deng XC
Biosci Biotechnol Biochem; 2020 Jun; 84(6):1160-1167. PubMed ID: 32125225
[TBL] [Abstract][Full Text] [Related]
2. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
3. Actin-like protein 8, a member of cancer/testis antigens, supports the aggressive development of oral squamous cell carcinoma cells via activating cell cycle signaling.
Wang L; Xing X; Tian H; Fan Q
Tissue Cell; 2022 Apr; 75():101708. PubMed ID: 35051678
[TBL] [Abstract][Full Text] [Related]
4. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
5. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
6. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
Lu M; Ding N; Zhuang S; Li Y
Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
Hu X; Han T; Bian Y; Tong H; Wen X; Li Y; Wan X
Oncol Rep; 2020 Mar; 43(3):919-929. PubMed ID: 32020231
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA SNHG12 regulates cell proliferation, invasion and migration in endometrial cancer by targeting miR‑4429.
Cai P; Wu M; Zhang B; Wu S; Wei H; Wei L
Mol Med Rep; 2020 Oct; 22(4):2842-2850. PubMed ID: 32945395
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
[TBL] [Abstract][Full Text] [Related]
11. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
12. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
15. ATP6V0D2, a subunit associated with proton transport, serves an oncogenic role in esophagus cancer and is correlated with epithelial-mesenchymal transition.
Qi M; Liu DM; Ji W; Wang HL
Esophagus; 2020 Oct; 17(4):456-467. PubMed ID: 32240421
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
[TBL] [Abstract][Full Text] [Related]
18. BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of ERK/MEK signaling pathway.
Lu Y; Lu H; Yang X; Song W
Reprod Biol; 2021 Jun; 21(2):100502. PubMed ID: 33784561
[TBL] [Abstract][Full Text] [Related]
19. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
20. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
